tnα biology inhibitor significantly improv clinic outcome mani autoimmune disease particular rheumatoid arthritis howe practice use limit due high cost risk antidrug antibody response attempt develop antitnfα vaccine genre encourage data anim model trial met expect present studi design epitopescaffold immunogen dtf use transmembrane domain diphtheria toxin name tt scaffold molecular dunam simply show graft editor entire surfaceexpos present natively conform rigid helix structure mini aperture thereby render highly stable immune mouse alum formal induce humor native tier sustain month support role universe cd cell editor break selfimmun tower mouse model dtnfalum vaccine markedly delay onset collageninduc reduce rcid well score presume safe carrier catalyst intact mutant crm good safety record active vaccine common taken together show database promise strategy prevent treatment 